Stocktoria
Maze Therapeutics, Inc. MAZE
Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2025-01-31
Maze Therapeutics, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| CITADEL ADVISORS LLC | 809,214 | $24.2M | 1.64% |
| D. E. Shaw & Co., Inc. | 45,636 | $1.4M | 0.09% |
| MILLENNIUM MANAGEMENT LLC | 29,892 | $892,276 | 0.06% |
| AQR CAPITAL MANAGEMENT LLC | 27,945 | $834,158 | 0.06% |
| TWO SIGMA INVESTMENTS, LP | 15,845 | $472,973 | 0.03% |
| RENAISSANCE TECHNOLOGIES LLC | 15,800 | $471,630 | 0.03% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.